Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid - PubMed
- ️Fri Jan 01 1982
Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid
M J Iadarola et al. Science. 1982.
Abstract
Localization of the anatomic substrate for anticonvulsant activity mediated by gamma-aminobutyric acid (GABA) was examined using intracerebral injections of GABA agonists. Blockade of tonic hindlimb extension in the maximal electroshock test and blockade of tonic and clonic seizures produced by pentylenetetrazole and bicuculline were obtained by elevating GABA in the ventral midbrain tegmentum. Elevation of GABA in forebrain and hindbrain areas had no effect on convulsant activity. Blockade of tonic and clonic seizures was also obtained after microinjections of the direct GABA receptor agonist, muscimol, into the midbrain. The substantia nigra was identified as the critical midbrain site for GABA-mediated anticonvulsant activity. Local injection of GABA agonists into the midbrain provided seizure protection without a widespread augmentation of GABA-mediated activity throughout the brain and without impairing either alertness or motor function. Synapses in the substantia nigra appear to represent an important control mechanism for inhibiting the propagation of generalized convulsions.
Similar articles
-
Anticonvulsant action of GABA receptor blockade in the nigrotectal target region.
Dean P, Gale K. Dean P, et al. Brain Res. 1989 Jan 16;477(1-2):391-5. doi: 10.1016/0006-8993(89)91434-0. Brain Res. 1989. PMID: 2539235
-
Lack of proconvulsant action of GABA depletion in substantia nigra in several seizure models.
Maggio R, Sohn E, Gale K. Maggio R, et al. Brain Res. 1991 Apr 26;547(1):1-6. doi: 10.1016/0006-8993(91)90567-f. Brain Res. 1991. PMID: 1650283
-
Redgrave P, Simkins M, overton P, Dean P. Redgrave P, et al. Neuroscience. 1992;46(2):379-90. doi: 10.1016/0306-4522(92)90059-b. Neuroscience. 1992. PMID: 1542413
-
GABA and epilepsy: their complex relationship and the evolution of our understanding.
Snodgrass SR. Snodgrass SR. J Child Neurol. 1992 Jan;7(1):77-86. doi: 10.1177/088307389200700114. J Child Neurol. 1992. PMID: 1313057 Review.
Cited by
-
Turski L, Cavalheiro EA, Calderazzo-Filho LS, Bortolotto ZA, Klockgether T, Ikonomidou C, Turski WA. Turski L, et al. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1694-7. doi: 10.1073/pnas.86.5.1694. Proc Natl Acad Sci U S A. 1989. PMID: 2922406 Free PMC article.
-
Molecular targets for antiepileptic drug development.
Meldrum BS, Rogawski MA. Meldrum BS, et al. Neurotherapeutics. 2007 Jan;4(1):18-61. doi: 10.1016/j.nurt.2006.11.010. Neurotherapeutics. 2007. PMID: 17199015 Free PMC article. Review.
-
Nolte MW, Löscher W, Herden C, Freed WJ, Gernert M. Nolte MW, et al. Neurobiol Dis. 2008 Sep;31(3):342-54. doi: 10.1016/j.nbd.2008.05.010. Epub 2008 Jul 15. Neurobiol Dis. 2008. PMID: 18632280 Free PMC article.
-
Guo H, Zhang H, Kuang Y, Wang C, Jing X, Gu J, Gao G. Guo H, et al. J Mol Neurosci. 2014 Aug;53(4):546-52. doi: 10.1007/s12031-013-0220-4. Epub 2014 Jan 8. J Mol Neurosci. 2014. PMID: 24399411
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical